Cross-Protective Efficacy of Influenza Virus M2e Containing Virus-Like Particles Is Superior to Hemagglutinin Vaccines and Variable Depending on the Genetic Backgrounds of Mice.
about
Porous Nanoparticles With Self-Adjuvanting M2e-Fusion Protein and Recombinant Hemagglutinin Provide Strong and Broadly Protective Immunity Against Influenza Virus InfectionsComplement C3 Plays a Key Role in Inducing Humoral and Cellular Immune Responses to Influenza Virus Strain-Specific Hemagglutinin-Based or Cross-Protective M2 Extracellular Domain-Based Vaccination
P2860
Cross-Protective Efficacy of Influenza Virus M2e Containing Virus-Like Particles Is Superior to Hemagglutinin Vaccines and Variable Depending on the Genetic Backgrounds of Mice.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Cross-Protective Efficacy of I ...... e Genetic Backgrounds of Mice.
@en
Cross-Protective Efficacy of I ...... e Genetic Backgrounds of Mice.
@nl
type
label
Cross-Protective Efficacy of I ...... e Genetic Backgrounds of Mice.
@en
Cross-Protective Efficacy of I ...... e Genetic Backgrounds of Mice.
@nl
prefLabel
Cross-Protective Efficacy of I ...... e Genetic Backgrounds of Mice.
@en
Cross-Protective Efficacy of I ...... e Genetic Backgrounds of Mice.
@nl
P2093
P2860
P356
P1476
Cross-Protective Efficacy of I ...... e Genetic Backgrounds of Mice.
@en
P2093
Jae-Min Song
Ki-Hye Kim
Min-Chul Kim
Sang-Moo Kang
Young-Tae Lee
Yu-Jin Kim
P2860
P356
10.3389/FIMMU.2017.01730
P577
2017-12-08T00:00:00Z